Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.8.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.8.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.8.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CA.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CA.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CA.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.61NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
ED.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
ED.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ED.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BU.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BU.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.3.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCGNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCGNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DT.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DT.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DT.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCANUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCANYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCANChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.54NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.77 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used